retatrutide dosing phase 2 trial Guide: 2mg–12mg Protocol + Calculator Retatrutide Dosage Chart: 2mg to

Biology (Basel)

While GLP-1 and GIP respond to sustained moderate levels, glucagon receptor activation appears more threshold-dependent

Common adverse reactions include nausea, belching, acid reflux with heartburn, diarrhea, vomiting, constipation, abdominal discomfort, fatigue, injection site reactions, and hypersensitivity reactions

Enebo, L

Common Adverse Events The most common adverse events in Phase 2 trials were gastrointestinal in nature, reflecting the class effects of GLP-1 receptor activation on gastric motility and central appetite pathways

contraindicated in uncontrolled hypertension and seizure disorders Orlistat (Xenical, Alli): Lipase inhibitor reducing dietary fat absorption, with modest 3-4% weight loss